Company: KNRX
Filing Date: 2025-06-12
Form Type: F-1/A
Source: 0001641172-25-014801
Chunk: 217

Company: KNOREX LTD.
Filing Date: 2025-06-12
Form: F-1/A
Chunk 217
---
2023, the Company has 4,780,575 Class B Ordinary Shares issued and outstanding.

Warrants

On March 30, 2023, the Company issued a total of 2,328,150 warrants to its ordinary shares investors in connection with an ordinary share equity financing. The Company estimates that the fair value of the warrants on the date of grant is US$7,418,954, using Black-Scholes Model. The fair value of the warrants is estimated using the following assumptions: (1) expected volatility of 68.14% using comparable companies, (2) risk-free interest rate of 4.10%, (3) expected life of 2 years, (4) exercise price of US$1.58 and (5) stock price of US$1.58.

| F-24 |

On October 30, 2023, the Company issued a total of 2,853,925 warrants to its ordinary shares investors in connection with an ordinary share equity financing. The Company estimates that the fair value of the warrants on the date of grant is US$9,063,846, using Black-Scholes Model. The fair value of the warrants is estimated using the following assumptions: (1) expected volatility of 63.11% using comparable companies, (2) risk-free interest rate of 5.03%, (3) expected life of 2 years, (4) exercise price of US$1.58 and (5) stock price of US$1.58.

The Company then applied the relative fair value of the warrants of US$2,455,068 and US$3,006,167 into capital and recognized the same value as a deemed dividend at the time of issuance, respectively.

On April 1, 2024, the Company issued a total of 251,608 warrants to the Company’s Class A Ordinary Shares investors in connection Class A Ordinary Share equity financing. The Company estimates that the fair value of the warrants on the date of grant is US$277,609, using Black-Scholes Model. The fair value of the warrants is estimated using the following assumptions: (1) expected volatility of 56.83% using comparable companies, (2) risk-free interest rate of 4.72%, (3) expected life of 2 years, (4) exercise price of US$3.33 (70% of stock price), and (5) stock price of US$4.75 (the midpoint of the estimated